Stephen Initiates This Spatial Biology Player Citing Strong Competitive Position
Stephens started coverage on Akoya Biosciences Inc (NASDAQ:AKYA) with an Overweight rating and price target of $16. The analyst views Akoya…
Akoya Biosciences’s Return On Capital Employed Insights
Akoya Biosciences (NASDAQ:AKYA) brought in sales totaling $17.89 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 6.68%, resulting in a loss of $17.50 million.
Akoya Biosciences: Q2 Earnings Insights
Akoya Biosciences (NASDAQ:AKYA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
A Preview Of Akoya Biosciences’s Earnings
Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.
Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.37.